The global stroke management market is anticipated to grow at a considerable CAGR of 6.9% during the forecast period (2021-2027). The rising pervasiveness of cardiovascular diseases is one of the prime factors affecting and driving the market. According to the World Health Organization (WHO) around 17.9 million people across the globe die due to cardiovascular diseases (CVD) every year. This highlights the fact that around 31% of total death occurrences are caused due to it. People may be indicated with high blood pressure, glucose, and lipids along with overweight and obesity those who have a high risk of CVD. Measurement of symptoms of this disease is a must in order to receive proper treatment for preventing premature deaths due to CVD. Additionally, a primary health care facility provides a convenient offering for measuring and providing proper treatment and counseling related to CVD.
Browse the full report description of "Global Stroke Management Market Research By Stroke Type (Ischemic Stroke, Hemorrhagic Stroke and Transient Ischemic Attack (TIA), By Diagnosis Method (Imaging Method and Blood Test), and By Therapeutics (Intravenous Injection of Tissue Plasminogen Activator (TPA), Antiplatelet, Anticoagulant and Antihypertensive) Forecast 2021-2027" at https://www.omrglobal.com/industry-reports/stroke-management-market
To gain on the opportunity key players operating in the global stroke management market had been adopting expansion strategies such as new launches. For instance, in September 2020, Cerenovus which is a part of Johnson & Johnson Services, Inc., had announced the introduction of the Cerenovus stroke solution. This solution includes three devices in order to support physicians in the procedure related to clot removal.
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
o By Stroke Type
o By Diagnosis Method
o By Therapeutics
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Stroke Management Market
By Stroke Type
• Ischemic Stroke
• Hemorrhagic Stroke
• Transient Ischemic Attack (TIA)
By Diagnosis Method
• Imaging Method
• Blood Test
By Therapeutics
• Intravenous Injection of Tissue Plasminogen Activator (TPA)
• Antiplatelet
• Anticoagulant
• Antihypertensive
Global Stroke Management Market by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/stroke-management-market